ArticleArthritis research & therapy2026
Molecular classification of primary Sjögren's syndrome based on salivary gland omics.
Article in Arthritis research & therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Primary Sjögren's syndrome is a complex and heterogeneous disease, often involving multiple organ systems and carrying an increased risk of lymphoma development. In this study, we integrated single-cell RNA sequencing and bulk RNA-seq data to deconvolute the disease heterogeneity using non-negative matrix factorization.This analysis identified four distinct molecular subtypes, which we designated as the Classical Immune Type, Ion Channel Type, Fibrotic Senescent Type, and Immune Desert Type. Through differential expression analysis, we further identified characteristic gene sets for each of these subtypes. The Gene Set Variation Analysis scores of these subtype-specific gene signatures in patient minor salivary gland RNA-seq data may potentially inform patient stratification. We preliminarily characterized the clinical features and local immune microenvironment profiles associated with each subtype. These findings may have implications for personalized therapeutic strategies and potentially inform the selection of patients for future clinical trials.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.